• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.

作者信息

Sellers T D, Bashore T M, Gallagher J J

出版信息

Circulation. 1977 Aug;56(2):260-7. doi: 10.1161/01.cir.56.2.260.

DOI:10.1161/01.cir.56.2.260
PMID:872319
Abstract

The effect of digitalis in 21 patients with Wolff-Parkinson-White syndrome was anlayzed with respect to the ventricular response during atrial fibrillation and antegrade and retrograde refractory periods of accessory pathways. Digitalis shortened the cycle length of the most rapid ventricular response (shortest R-R) (i.e., increased the ventricle response) in 6/21 patients, increased the cycle length in 7/21 patients, had no effect on the cycle length in 5/21, and could not be determined in 3/21. Digitalis could be directly related to the onset of ventricle fibrillation resulting from atrial fibrillation in 9/21 patients. Each of these patients had shortest R-R intervals (220 msec or less) during atrial fibrillation in the control data. The results of this study indicate that no a priori prediction about the effect of digitalis on the antegrade conduction of accessory pathways can be made. By elective induction of atrial fibrillation it is possible to separate WPW patients into groups at high and low risk for developing ventricular fibrillation with the administration of digitalis.

摘要

相似文献

1
Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
Circulation. 1977 Aug;56(2):260-7. doi: 10.1161/01.cir.56.2.260.
2
Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Am J Med. 1994 Jul;97(1):25-8. doi: 10.1016/0002-9343(94)90044-2.
3
Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.磷酸丙吡胺对预激综合征患者的电生理效应。
Circulation. 1982 May;65(5):869-78. doi: 10.1161/01.cir.65.5.869.
4
Sinus bradycardia and atrial fibrillation associated with the Wolff-Parkinson-White syndrome.
Am J Cardiol. 1976 Aug;38(2):149-56. doi: 10.1016/0002-9149(76)90141-7.
5
Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response.
Am Heart J. 1984 Oct;108(4 Pt 1):905-9. doi: 10.1016/0002-8703(84)90453-8.
6
Intermittent Wolff-Parkinson-White syndrome due to phase 3 and phase 4 block: disappearance of rapid ventricular response during atrial fibrillation.由3相和4相阻滞引起的间歇性预激综合征:房颤时快速心室反应消失
J Electrocardiol. 1988 Jan;21(1):77-82. doi: 10.1016/s0022-0736(88)80027-x.
7
Refractory periods of the accessory pathway in the Wolff-Parkinson-White syndrome.预激综合征旁路的不应期
Circulation. 1975 Oct;52(4):563-9. doi: 10.1161/01.cir.52.4.563.
8
Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.维拉帕米对预激综合征患者旁路电生理特性的影响。
Am J Cardiol. 1982 Dec;50(6):1323-30. doi: 10.1016/0002-9149(82)90470-2.
9
Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.预激综合征与心房颤动。心房颤动时旁路不应期与心室率的关系。
Am J Cardiol. 1974 Dec;34(7):777-82. doi: 10.1016/0002-9149(74)90695-x.
10
Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.劳卡尼对预激综合征旁路的电生理效应。
Am J Cardiol. 1983 Jun;51(10):1618-22. doi: 10.1016/0002-9149(83)90197-2.

引用本文的文献

1
Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC.抗心律失常药物实用手册:欧洲心脏病学会(ESC)欧洲心律协会临床共识声明
Europace. 2025 Mar 30. doi: 10.1093/europace/euaf076.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
3
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
4
Approach to a patient with asymptomatic pre-excitation.无症状预激患者的处理方法。
Heart. 2023 Jul 27;109(16):1254-1259. doi: 10.1136/heartjnl-2022-321639.
5
Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation.胺碘酮对预激综合征合并心房颤动患者的电生理及治疗作用
J Res Med Sci. 2022 Sep 27;27:69. doi: 10.4103/jrms.jrms_91_22. eCollection 2022.
6
Acute rate control in atrial fibrillation: an urgent need for the clinician.心房颤动的急性心率控制:临床医生的迫切需求。
Eur Heart J Suppl. 2022 Jun 13;24(Suppl D):D3-D10. doi: 10.1093/eurheartjsupp/suac022. eCollection 2022 Jun.
7
Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia.胎儿室上性心动过速抗心律失常治疗期间的母体监测及安全性考量
Obstet Med. 2019 Jun;12(2):66-75. doi: 10.1177/1753495X18808118. Epub 2018 Nov 15.
8
Management of Supraventricular Tachycardia in Infants.婴儿室上性心动过速的管理
Paediatr Drugs. 2017 Dec;19(6):539-551. doi: 10.1007/s40272-017-0254-0.
9
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).执行摘要:欧洲心律协会室上性心律失常管理共识文件:得到心律学会(HRS)、亚太心律学会(APHRS)和拉丁美洲心脏刺激与电生理学会(SOLAECE)认可。
Arrhythm Electrophysiol Rev. 2016;5(3):210-224. doi: 10.15420/aer.2016:5.3.GL1.
10
Variability in the manifestation of pre-excited atrial fibrillation: its quantification, theoretical origin, and diagnostic potential.预激性心房颤动表现的变异性:其量化、理论起源及诊断潜力
Ann Noninvasive Electrocardiol. 2001 Apr;6(2):117-22. doi: 10.1111/j.1542-474x.2001.tb00095.x.